These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21401867)

  • 1. The economic implications of broader sharing of liver allografts.
    Axelrod DA; Gheorghian A; Schnitzler MA; Dzebisashvili N; Salvalaggio PR; Tuttle-Newhall J; Segev DL; Gentry S; Hohmann S; Merion RM; Lentine KL
    Am J Transplant; 2011 Apr; 11(4):798-807. PubMed ID: 21401867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial Impact of Liver Sharing and Organ Procurement Organizations' Experience With Share 35: Implications for National Broader Sharing.
    Fernandez H; Weber J; Barnes K; Wright L; Levy M
    Am J Transplant; 2016 Jan; 16(1):287-91. PubMed ID: 26372681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing variation in the costs of care among patients awaiting liver transplantation.
    Axelrod DA; Dzebisashvili N; Lentine K; Segev DL; Dickson R; Tuttle-Newhall E; Freeman R; Schnitzler M
    Am J Transplant; 2014 Jan; 14(1):70-8. PubMed ID: 24165015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Share 35 on the cost of liver transplantation.
    Berumen J; Misel M; Vodkin I; Halldorson JB; Mekeel KL; Hemming A
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.
    Foxton MR; Al-Freah MA; Portal AJ; Sizer E; Bernal W; Auzinger G; Rela M; Wendon JA; Heaton ND; O'Grady JG; Heneghan MA
    Liver Transpl; 2010 May; 16(5):668-77. PubMed ID: 20440776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation.
    Kogure T; Ueno Y; Kawagishi N; Kanno N; Yamagiwa Y; Fukushima K; Satomi S; Shimosegawa T
    J Gastroenterol; 2006 Oct; 41(10):1005-10. PubMed ID: 17096070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission.
    Buchanan P; Dzebisashvili N; Lentine KL; Axelrod DA; Schnitzler MA; Salvalaggio PR
    Liver Transpl; 2009 Oct; 15(10):1270-7. PubMed ID: 19790155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.
    Salvalaggio PR; Dzebisashvili N; MacLeod KE; Lentine KL; Gheorghian A; Schnitzler MA; Hohmann S; Segev DL; Gentry SE; Axelrod DA
    Liver Transpl; 2011 Mar; 17(3):233-42. PubMed ID: 21384505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation.
    Ichida T; Narita Y; Murakami R
    J Gastroenterol; 2006 Oct; 41(10):1023-4. PubMed ID: 17096073
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospital Resource Use with Donation after Cardiac Death Allografts in Liver Transplantation: A Matched Controlled Analysis from 2007 to 2011.
    Singhal A; Wima K; Hoehn RS; Quillin RC; Woodle ES; Paquette IM; Paterno F; Abbott DE; Shah SA
    J Am Coll Surg; 2015 May; 220(5):951-8. PubMed ID: 25840540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost prediction in liver transplantation using pretransplant donor and recipient characteristics.
    Earl TM; Cooil B; Rubin JE; Chari RS
    Transplantation; 2008 Jul; 86(2):238-44. PubMed ID: 18645485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic impact of the utilization of liver allografts with high donor risk index.
    Axelrod DA; Schnitzler M; Salvalaggio PR; Swindle J; Abecassis MM
    Am J Transplant; 2007 Apr; 7(4):990-7. PubMed ID: 17391139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost Analysis of Liver Acquisition Fees Before and After Acuity Circle Policy Implementation.
    Wall AE; da Graca B; Asrani SK; Ruiz R; Fernandez H; Gupta A; Martinez E; Bayer J; McKenna GJ; Goldstein R; Onaca N; Trotter JF; Testa G
    JAMA Surg; 2021 Nov; 156(11):1051-1057. PubMed ID: 34495291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of broader regional sharing of livers: 2-year results of "Share 35".
    Edwards EB; Harper AM; Hirose R; Mulligan DC
    Liver Transpl; 2016 Apr; 22(4):399-409. PubMed ID: 26890858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Same policy, different impact: Center-level effects of share 35 liver allocation.
    Murken DR; Peng AW; Aufhauser DD; Abt PL; Goldberg DS; Levine MH
    Liver Transpl; 2017 Jun; 23(6):741-750. PubMed ID: 28407441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study.
    Lee J; Lee JG; Jung I; Joo DJ; Kim SI; Kim MS;
    Sci Rep; 2019 May; 9(1):7495. PubMed ID: 31097768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost analysis of liver transplantation in a community hospital: association with the Model for End-stage Liver Disease, a prognostic index to prioritize the most severe patients].
    Boerr E; Anders M; Mella J; Quiñonez E; Goldaracena N; Orozco F; McCormack L; Mastai R
    Gastroenterol Hepatol; 2013 Jan; 36(1):1-6. PubMed ID: 23123035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality.
    Nicolas CT; Nyberg SL; Heimbach JK; Watt K; Chen HS; Hathcock MA; Kremers WK
    Liver Transpl; 2017 Jan; 23(1):11-18. PubMed ID: 27658200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.